STOCK TITAN

Monthly information on share capital and company voting rights

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Cellectis (CLLS) has released its monthly share capital and voting rights report as of April 30, 2025. The company reported a total of 100,290,220 shares in its capital structure, with 89,075,490 total voting rights. This disclosure is made in accordance with Article 223-16 of the General Regulation of the French financial markets authority, as the company is listed on Euronext Growth.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – CLLS

+0.33%
1 alert
+0.33% News Effect

On the day this news was published, CLLS gained 0.33%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, May 07, 2025 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

DateTotal number of shares
in the capital
Total number of voting rights
04/30/2025100,290,22089,075,490


For further information on Cellectis, please contact:
     

Media contacts:       

Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com

Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93

Investor Relations contact:       

Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@cellectis.com


Attachment


FAQ

What is the current number of shares outstanding for Cellectis (CLLS) as of April 2025?

As of April 30, 2025, Cellectis has 100,290,220 total shares outstanding in its capital structure.

How many voting rights does Cellectis (CLLS) have as of April 2025?

Cellectis reported 89,075,490 total voting rights as of April 30, 2025.

Why is there a difference between Cellectis (CLLS) total shares and voting rights?

The difference between total shares (100,290,220) and voting rights (89,075,490) may be due to factors such as treasury shares, which typically don't carry voting rights, or different share classes with varying voting rights.

Where is Cellectis (CLLS) stock listed?

Cellectis (CLLS) is listed on Euronext Growth market.
Cellectis

NASDAQ:CLLS

View CLLS Stock Overview

CLLS Rankings

CLLS Latest News

CLLS Latest SEC Filings

CLLS Stock Data

320.89M
72.34M
Biotechnology
Healthcare
Link
France
Paris